215 related articles for article (PubMed ID: 25551563)
1. MiR-145 expression accelerates esophageal adenocarcinoma progression by enhancing cell invasion and anoikis resistance.
Derouet MF; Liu G; Darling GE
PLoS One; 2014; 9(12):e115589. PubMed ID: 25551563
[TBL] [Abstract][Full Text] [Related]
2. microRNAs: Key regulators of chemotherapy response and metastatic potential via complex control of target pathways in esophageal adenocarcinoma.
Matuszcak C; Lindner K; Eichelmann AK; Hussey DJ; Haier J; Hummel R
Surg Oncol; 2018 Sep; 27(3):392-401. PubMed ID: 30217293
[TBL] [Abstract][Full Text] [Related]
3. Complex Epigenetic Regulation of Chemotherapy Resistance and Biohlogy in Esophageal Squamous Cell Carcinoma via MicroRNAs.
Lindner K; Eichelmann AK; Matuszcak C; Hussey DJ; Haier J; Hummel R
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414899
[TBL] [Abstract][Full Text] [Related]
4. Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN.
Jin YY; Chen QJ; Xu K; Ren HT; Bao X; Ma YN; Wei Y; Ma HB
Mol Cell Biochem; 2016 Nov; 422(1-2):161-170. PubMed ID: 27644195
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines.
Hummel R; Sie C; Watson DI; Wang T; Ansar A; Michael MZ; Van der Hoek M; Haier J; Hussey DJ
World J Gastroenterol; 2014 Oct; 20(40):14904-12. PubMed ID: 25356050
[TBL] [Abstract][Full Text] [Related]
6. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J
Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377
[TBL] [Abstract][Full Text] [Related]
7. MiR-21 Suppresses Anoikis through Targeting PDCD4 and PTEN in Human Esophageal Adenocarcinoma.
Zhao MY; Wang LM; Liu J; Huang X; Liu J; Zhang YF
Curr Med Sci; 2018 Apr; 38(2):245-251. PubMed ID: 30074182
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced modification of microRNA expression in esophageal cancer.
Hummel R; Wang T; Watson DI; Michael MZ; Van der Hoek M; Haier J; Hussey DJ
Oncol Rep; 2011 Oct; 26(4):1011-7. PubMed ID: 21743970
[TBL] [Abstract][Full Text] [Related]
9. miR-145 inhibits proliferation and invasion of esophageal squamous cell carcinoma in part by targeting c-Myc.
Wang F; Xia J; Wang N; Zong H
Onkologie; 2013; 36(12):754-8. PubMed ID: 24356567
[TBL] [Abstract][Full Text] [Related]
10. miR-221 Mediates Chemoresistance of Esophageal Adenocarcinoma by Direct Targeting of DKK2 Expression.
Wang Y; Zhao Y; Herbst A; Kalinski T; Qin J; Wang X; Jiang Z; Benedix F; Franke S; Wartman T; Camaj P; Halangk W; Kolligs FT; Jauch KW; Nelson PJ; Bruns CJ
Ann Surg; 2016 Nov; 264(5):804-814. PubMed ID: 27501171
[TBL] [Abstract][Full Text] [Related]
11. MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus.
Hezova R; Kovarikova A; Srovnal J; Zemanova M; Harustiak T; Ehrmann J; Hajduch M; Sachlova M; Svoboda M; Slaby O
Tumour Biol; 2016 Jun; 37(6):8007-18. PubMed ID: 26711784
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors (PPIs) impact on tumour cell survival, metastatic potential and chemotherapy resistance, and affect expression of resistance-relevant miRNAs in esophageal cancer.
Lindner K; Borchardt C; Schöpp M; Bürgers A; Stock C; Hussey DJ; Haier J; Hummel R
J Exp Clin Cancer Res; 2014 Sep; 33(1):73. PubMed ID: 25175076
[TBL] [Abstract][Full Text] [Related]
13. Altered miRNA expression is associated with differentiation, invasion, and metastasis of esophageal squamous cell carcinoma (ESCC) in patients from Huaian, China.
Fu HL; Wu DP; Wang XF; Wang JG; Jiao F; Song LL; Xie H; Wen XY; Shan HS; Du YX; Zhao YP
Cell Biochem Biophys; 2013 Nov; 67(2):657-68. PubMed ID: 23516093
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.
Zhou S; Yang B; Zhao Y; Xu S; Zhang H; Li Z
J Surg Res; 2014 Dec; 192(2):515-20. PubMed ID: 25218280
[TBL] [Abstract][Full Text] [Related]
15. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.
Hong L; Han Y; Zhang H; Li M; Gong T; Sun L; Wu K; Zhao Q; Fan D
Ann Surg; 2010 Jun; 251(6):1056-63. PubMed ID: 20485139
[TBL] [Abstract][Full Text] [Related]
16. miR-145 expression enhances integrin expression in SK-GT-4 cell line by down-regulating c-Myc expression.
Derouet MF; Dakpo E; Wu L; Zehong G; Conner J; Keshavjee S; de Perrot M; Waddell T; Elimova E; Yeung J; Darling GE
Oncotarget; 2018 Mar; 9(20):15198-15207. PubMed ID: 29632636
[TBL] [Abstract][Full Text] [Related]
17. Suppression of anoikis by SKP2 amplification and overexpression promotes metastasis of esophageal squamous cell carcinoma.
Wang XC; Wu YP; Ye B; Lin DC; Feng YB; Zhang ZQ; Xu X; Han YL; Cai Y; Dong JT; Zhan QM; Wu M; Wang MR
Mol Cancer Res; 2009 Jan; 7(1):12-22. PubMed ID: 19147533
[TBL] [Abstract][Full Text] [Related]
18. Low miR-187 expression promotes resistance to chemoradiation therapy in vitro and correlates with treatment failure in patients with esophageal adenocarcinoma.
Lynam-Lennon N; Bibby BA; Mongan AM; Marignol L; Paxton CN; Geiersbach K; Bronner MP; O'Sullivan J; Reynolds J; Maher SG
Mol Med; 2016 May; 22():388-97. PubMed ID: 27254108
[TBL] [Abstract][Full Text] [Related]
19. microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients.
Mari L; Hoefnagel SJM; Zito D; van de Meent M; van Endert P; Calpe S; Sancho Serra MDC; Heemskerk MHM; van Laarhoven HWM; Hulshof MCCM; Gisbertz SS; Medema JP; van Berge Henegouwen MI; Meijer SL; Bergman JJGHM; Milano F; Krishnadath KK
Gastroenterology; 2018 Sep; 155(3):784-798. PubMed ID: 29885883
[TBL] [Abstract][Full Text] [Related]
20. Atypical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCι-SKP2-AKT pathway.
Liu SG; Wang BS; Jiang YY; Zhang TT; Shi ZZ; Yang Y; Yang YL; Wang XC; Lin DC; Zhang Y; Yang H; Cai Y; Zhan QM; Wang MR
Mol Cancer Res; 2011 Apr; 9(4):390-402. PubMed ID: 21310827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]